This annual conference will discuss the expanding Point-of-Care Diagnostics and Global Health fields and bring in the Emerging Viral Diseases field providing the most up-to-date presentations from leaders in these fields and offer networking and engagement opportunities with delegates from around the world.
This conference will provide an overview of the point-of-care (POC) testing landscape, from novel technologies to regulatory approval. Experts in these fields will share their views on point-of-care in the clinical setting. The aim of this meeting is to bring together life science researchers that work at the interface between biology and chemistry and technology development to discuss problems, highlight solutions and facilitating collaborations. Also, we frame the role of POC testing in the expanding Global Health field and highlight opportunities existing in many parts of the world.
This conference covers POC Detection, POC Diagnostics and POC-based Treatment Options as part of the Comprehensive Coverage of this Expanding Field. The POC testing field is expanding focused not only on infectious disease diagnostics (which represents approximately 80% of the marketplace) but also with cancer and cardiovascular disease focus. We address each of these segments in this conference.
Agenda:
Emerging Technologies and Emerging Companies Showcase
Global Health and Emerging Viral Diseases such as Ebola and Zika
Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
Innovations in Technology Development
POC Diagnostics for Global Health: A Worldwide Perspective
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference.
On April 26, 2024, the hearing will commence 11:15 a.m.
Members of the public may observe the hearing by videoconference, by...
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market...
Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings.
SONIFI Health is a leading U.S. healthcare technology company based in Sioux...